Company Filing History:
6 out of 118 
1 out of 73 
1 out of 5 
Years Active: 2006-2022
Title: Paul Michael O'Neill: Innovator and Inventor from Liverpool
Introduction
Paul Michael O'Neill, a distinguished inventor based in Liverpool, GB, has made significant contributions to the fields of medicine and pharmacology. With a total of eight patents to his name, O'Neill has developed innovative solutions aimed at combating various health issues, particularly focusing on infections caused by filarial worms and mycobacterial infections.
Latest Patents
Among his notable recent patents is the development of Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds. This invention encompasses compounds of specific formulae, alongside salts and solvates, and aims to provide effective pharmaceutical compositions for the treatment or prevention of filarial worm infections and related diseases.
Additionally, O'Neill's patent concerning the combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor highlights his commitment to tackling mycobacterial infections, including tuberculosis. This patent details a therapeutic product made from a combination of inhibitors and emphasizes its potential application in pharmaceutical formulations.
Career Highlights
Throughout his career, Paul Michael O'Neill has been associated with prestigious institutions, notably the University of Liverpool and the University of Dundee. His work at these universities has enabled him to bridge the gap between academic research and practical medical applications, contributing valuable insights into infectious disease treatments.
Collaborations
During his innovative journey, O'Neill has collaborated with brilliant minds such as Martin Leuwer and Neil Berry. These partnerships have played a crucial role in the development and success of his inventions, showcasing the importance of teamwork in advancing scientific research.
Conclusion
Paul Michael O'Neill stands out as a notable inventor in the realm of pharmaceuticals. His contributions through his patents not only reflect his ingenuity but also provide hope for better treatments against challenging infections. His ongoing work continues to inspire innovation and collaboration within the scientific community, reinforcing the importance of research in improving global health outcomes.